These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4944450)

  • 21. Modification of mouse islet function by 5-hydroxytryptamine, dopamine and their precursors.
    Lindstöm P
    Acta Biol Med Ger; 1982; 41(12):1185-90. PubMed ID: 6765161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of insulin release by substrates and inhibitors of monoamine oxidase.
    Aleyassine H; Lee SH
    Am J Physiol; 1972 Mar; 222(3):565-9. PubMed ID: 5022664
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo.
    Carlsson A; Lindqvist M
    J Neural Transm; 1972; 33(1):23-43. PubMed ID: 4264576
    [No Abstract]   [Full Text] [Related]  

  • 24. The beta-cell capacity for insulin secretion in microdissected pancreatic islets from obese-hyperglycemic mice.
    Lernmark A; Hellman B
    Life Sci; 1969 Jan; 8(2):53-9. PubMed ID: 4905547
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta cell monoamines: further evidence for their role in modulating insulin secretion.
    Wilson JP; Downs RW; Feldman JM; Lebovitz HE
    Am J Physiol; 1974 Aug; 227(2):305-12. PubMed ID: 4152791
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice.
    Wilson GA; Furman BL
    Eur J Pharmacol; 1982 Mar; 78(3):263-70. PubMed ID: 7040087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of 5-hydroxytryptamine depletors and monoamine oxidase inhibitors on color changes of the fiddler crab, Uca pugilator: further evidence in support of the hypothesis that 5-hydroxytryptamine controls the release of red pigment-dispersing hormone.
    Fingerman M; Fingerman SW
    Comp Biochem Physiol C Comp Pharmacol; 1975 Oct; 52(1):55-9. PubMed ID: 205
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activity of toloxatone, antidepressive agents and various other reserpine antagonists on three behavior tests, in the mouse treated with nialamide].
    Gouret C; Raynaud G
    Therapie; 1975; 30(2):225-30. PubMed ID: 1080583
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the pharmacology of alpha-methyl-3,4-dihydroxyphenylalanine (alpha-methyl-dopa) and alpha-methylnorepinephrine. II.
    Kadzielawa K
    Int J Neuropharmacol; 1967 Nov; 6(6):453-62. PubMed ID: 5300898
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Effect of pancreozymin, secretin and gastrin pentapeptide on insulin secretion from the isolated islets of Langerhans of normal and obese hyperglycaemic mice.
    Best L; Atkins TW; Matty AJ
    J Endocrinol; 1974 May; 61(2):LXIX-LXX. PubMed ID: 4600122
    [No Abstract]   [Full Text] [Related]  

  • 33. Participation of serotonin in development of morphine dependence in mice and rats.
    Kruszewska A
    Pol J Pharmacol Pharm; 1980; 32(5):655-63. PubMed ID: 6973754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster.
    Zern RT; Bird JL; Feldman JM
    Diabetologia; 1980 Apr; 18(4):341-6. PubMed ID: 6998806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of cyclic AMP potentiation of glucose-stimulated insulin release.
    Lernmark A
    Horm Res; 1974; 5(4):227-33. PubMed ID: 4366458
    [No Abstract]   [Full Text] [Related]  

  • 36. Pancreatic biogenic amines and insulin secretion in health and disease.
    Lebovitz HE; Feldman JM
    Fed Proc; 1973 Jul; 32(7):1797-802. PubMed ID: 4198098
    [No Abstract]   [Full Text] [Related]  

  • 37. Preservation of insulin release periodicity from individual islets of obese Zucker rats.
    Hayek A
    Horm Metab Res; 1981 Feb; 13(2):119-20. PubMed ID: 7014407
    [No Abstract]   [Full Text] [Related]  

  • 38. The pancreatic -cell recognition of insulin secretagogues. I. Transport of mannoheptulose and the dynamics of insulin release.
    Hellman B; Idahl LA; Lernmark A; Sehlin J; Simon E; Täljedal IB
    Mol Pharmacol; 1972 Jan; 8(1):1-7. PubMed ID: 4551472
    [No Abstract]   [Full Text] [Related]  

  • 39. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
    [No Abstract]   [Full Text] [Related]  

  • 40. Serotonin binding to nerve ending particles and other preparations from rat brain.
    Marchbanks RM
    J Neurochem; 1966 Dec; 13(12):1481-93. PubMed ID: 5962026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.